Gastrointestinal infection test kit PG2225
bacteriaEscherichia colienterobacteriaceae

Gastrointestinal infection test kit - PG2225 - R-Biopharm AG - bacteria / Escherichia coli / enterobacteriaceae
Gastrointestinal infection test kit - PG2225 - R-Biopharm AG - bacteria / Escherichia coli / enterobacteriaceae
Add to favorites
Compare this product
 

Characteristics

Applications
for gastrointestinal infections
Micro-organism
bacteria, Escherichia coli, enterobacteriaceae, Shigella
Sample type
stool
Analysis mode
for real-time PCR

Description

For in vitro diagnostic use. RIDA®GENE ETEC/EIEC is a multiplex real-time PCR for the direct, qualitative detection and differentiation of the virulence-factor genes of ETEC and EIEC/Shigella spp. in human stool samples and cultures. RIDA®GENE ETEC/EIEC multiplex real-time PCR is intended for use as an aid in diagnosis of gastroenteritis caused by pathogenic Escherichia coli and Shigella spp., respectively. General information: Escherichia coli (E. coli) are gram negative, facultatively anaerobic rod bacteria, which move by peritrichal flagellation and belong to the Enterobacteriaceae family. E. coli are part of the normal intestinal flora of humans and many farm animals and are generally nonpathogenic. Some E. coli strains are pathogenic to humans through the acquisition of certain virulence factors (e.g. genes for toxins). The six known intestinal pathogenic E. coli: enterohemorrhagic E. coli (EHEC), enteropathogenic E. coli (EPEC), enterotoxic E. coli (ETEC), enteroinvasive E. coli (EIEC), EAEC enteroaggregative E. coli und diffusely adherent E. coli (DAEC) can be differentiated by the virulence factors. Enterotoxigenic E. coli (ETEC) are important intestinal pathogenic E. coli. ETEC is the most common cause of traveller’s diarrhea that affects persons travelling to developing countries. 30 – 60 % of all traveller’s diarrhea cases are caused by ETEC. 11 – 16 % of returning travellers from developing countries are infected by ETEC. Among children below 5 years of age in developing countries, ETEC accounts for about 210 million cases of diarrhea and about 380,000 deaths annually.

Catalogs

No catalogs are available for this product.

See all of R-Biopharm AG‘s catalogs

Other R-Biopharm AG products

Gastrointestinal infections

*Prices are pre-tax. They exclude delivery charges and customs duties and do not include additional charges for installation or activation options. Prices are indicative only and may vary by country, with changes to the cost of raw materials and exchange rates.